Literature DB >> 17499453

Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.

Timothy N Showalter1, Jocelyn Andrel, David W Andrews, Walter J Curran, Constantine Daskalakis, Maria Werner-Wasik.   

Abstract

PURPOSE: To assess the progression patterns in patients with multifocal glioblastoma multiforme who had undergone whole brain radiotherapy (WBRT), the historical standard, versus three-dimensional conformal radiotherapy, and to identify predictive treatment and pretreatment factors. METHODS AND MATERIALS: The records of 50 patients with multifocal glioblastoma multiforme treated with RT were reviewed. Univariate analyses were performed using survival methods and the Cox proportional hazards regression method. Multivariate analyses were performed using the Cox proportional hazards regression method.
RESULTS: The mean age was 61 years, and 71% had a Karnofsky performance status (KPS) score of > or =70. Of the 50 patients, 32% underwent WBRT and 68%, three-dimensional conformal RT. Progression was local in all evaluable patients, as determined by imaging in 38 patients and early neurologic progression in 12. The median time to progression (TTP) was 3.1 months, and the median survival time (MST) was 8.1 months. The significant independent predictors of TTP on multivariate analysis were a KPS score <70 (p = 0.001), the extent of surgery (p = 0.040), a radiation dose <60 Gy (p = 0.027), and the lack of chemotherapy (p = 0.001). The significant independent predictors of a reduced MST were a KPS score <70 (p = 0.022) and the absence of salvage surgery (p = 0.011) and salvage chemotherapy (p = 0.003).
CONCLUSION: Local progression was observed in all patients. On multivariate analysis, no significant difference was found in the TTP or MST between three-dimensional conformal radiotherapy and WBRT. The KPS was a consistent independent predictor of both TTP and MST. On the basis of the progression pattern, we do not recommend WBRT as a mandatory component of the treatment of multifocal glioblastoma multiforme.

Entities:  

Mesh:

Year:  2007        PMID: 17499453     DOI: 10.1016/j.ijrobp.2007.03.045

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  30 in total

1.  Morphologic Features on MR Imaging Classify Multifocal Glioblastomas in Different Prognostic Groups.

Authors:  J Pérez-Beteta; D Molina-García; M Villena; M J Rodríguez; C Velásquez; J Martino; B Meléndez-Asensio; Á Rodríguez de Lope; R Morcillo; J M Sepúlveda; A Hernández-Laín; A Ramos; J A Barcia; P C Lara; D Albillo; A Revert; E Arana; V M Pérez-García
Journal:  AJNR Am J Neuroradiol       Date:  2019-03-28       Impact factor: 3.825

2.  Association between medical academic genealogy and publication outcome: impact of unconscious bias on scientific objectivity.

Authors:  Brian R Hirshman; Ali A Alattar; Sanjay Dhawan; Kathleen M Carley; Clark C Chen
Journal:  Acta Neurochir (Wien)       Date:  2019-01-23       Impact factor: 2.216

3.  Patterns of imaging failures in glioblastoma patients treated with chemoradiation: a retrospective study.

Authors:  Hubert Pan; John Alksne; Arno J Mundt; Kevin T Murphy; Mariel Cornell; Santosh Kesari; Joshua D Lawson
Journal:  Med Oncol       Date:  2011-11-23       Impact factor: 3.064

4.  Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma.

Authors:  Anna K Paulsson; Jordan A Holmes; Ann M Peiffer; Lance D Miller; Wennuan Liu; Jianfeng Xu; William H Hinson; Glenn J Lesser; Adrian W Laxton; Stephen B Tatter; Waldemar Debinski; Michael D Chan
Journal:  J Neurooncol       Date:  2014-07-03       Impact factor: 4.130

5.  Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma.

Authors:  Qun Liu; Yuexin Liu; Wenliang Li; Xiaoguang Wang; Raymond Sawaya; Frederick F Lang; W K Alfred Yung; Kexin Chen; Gregory N Fuller; Wei Zhang
Journal:  Acta Neuropathol       Date:  2015-09-01       Impact factor: 17.088

Review 6.  Surgical resection of malignant gliomas-role in optimizing patient outcome.

Authors:  Ilker Y Eyüpoglu; Michael Buchfelder; Nic E Savaskan
Journal:  Nat Rev Neurol       Date:  2013-01-29       Impact factor: 42.937

7.  Multifocal glioblastoma multiforme with synchronous spontaneous hemorrhage: case report.

Authors:  Ronald J Benveniste; Glen Manzano; Carol K Petito
Journal:  J Neurooncol       Date:  2008-04-12       Impact factor: 4.130

8.  Neuroimaging classification of progression patterns in glioblastoma: a systematic review.

Authors:  Rory J Piper; Keerthi K Senthil; Jiun-Lin Yan; Stephen J Price
Journal:  J Neurooncol       Date:  2018-03-30       Impact factor: 4.130

9.  Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma.

Authors:  Emil Lou; Katherine B Peters; Ashley L Sumrall; Annick Desjardins; David A Reardon; Eric S Lipp; James E Herndon; April Coan; Leighann Bailey; Scott Turner; Henry S Friedman; James J Vredenburgh
Journal:  Cancer Med       Date:  2013-01-24       Impact factor: 4.452

10.  Pediatric multifocal glioblastoma multiforme with fulminant course.

Authors:  Goutham Cugati; Pradeep Kumar Jain; Anil Pande; Nigel Peter Symss; Vasudevan Chakravarthy; Ravi Ramamurthi
Journal:  J Neurosci Rural Pract       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.